Get started
InflaRx N.V.InflaRx N.V.InflaRx N.V.

InflaRx N.V.

No trades
See on Supercharts
Overview
Financials News Discussions Forecast Seasonals

IF0 chart


Full chart

IF0 upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪67.04 M‬ EUR
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
—
Net income (FY)
‪−48.13 M‬ EUR
Revenue (FY)
‪173.23 K‬ EUR
Shares float
‪62.81 M‬
Beta (1Y)
0.70

Employees


Employees (FY)
74
Change (1Y)
+8 +12.12%
Revenue / Employee (1Y)
—
Net income / Employee (1Y)
—

About InflaRx N.V.


Sector
Health Technology
Industry
Biotechnology
CEO
Niels Christoph Riedemann
Website
inflarx.de
Headquarters
Jena
Founded
2007
ISIN
NL0012661870
FIGI
BBG00J7RXCT7
InflaRx NV is a clinical-stage biopharmaceutical company, which engages in the discovery and development of inhibitors of the complement activation factor known as C5a and its receptor C5aR. Its primary product candidate is Vilobelimab. The company was founded by Niels Christoph Riedemann, Renfeng Guo, and Nicolas Fulpius in December 2007 and is headquartered in Jena, Germany.

Check out other big names from the same industry as IF0.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

IF0 news



Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


Depending on the exchange, the stock ticker may vary. For instance, on SWB exchange InflaRx N.V. stocks are traded under the ticker IF0.
We've gathered analysts' opinions on InflaRx N.V. future price: according to them, IF0 price has a max estimate of 8.60 EUR and a min estimate of 1.72 EUR. Watch IF0 chart and read a more detailed InflaRx N.V. stock forecast: see what analysts think of InflaRx N.V. and suggest that you do with its stocks.
IF0 reached its all-time high on Apr 29, 2019 with the price of 46.4000 EUR, and its all-time low was 0.6245 EUR and was reached on May 28, 2025. View more price dynamics on IF0 chart.
See other stocks reaching their highest and lowest prices.
Yes, you can track InflaRx N.V. financials in yearly and quarterly reports right on TradingView.
InflaRx N.V. is going to release the next earnings report on Oct 30, 2025. Keep track of upcoming events with our Earnings Calendar.
IF0 earnings for the last quarter are −0.21 EUR per share, whereas the estimation was −0.21 EUR resulting in a 0.00% surprise. The estimated earnings for the next quarter are −0.15 EUR per share. See more details about InflaRx N.V. earnings.
InflaRx N.V. revenue for the last quarter amounts to ‪39.43 K‬ EUR, despite the estimated figure of ‪39.43 K‬ EUR. In the next quarter, revenue is expected to reach ‪69.14 K‬ EUR.
IF0 net income for the last quarter is ‪−13.88 M‬ EUR, while the quarter before that showed ‪−8.09 M‬ EUR of net income which accounts for −71.63% change. Track more InflaRx N.V. financial stats to get the full picture.
No, IF0 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Sep 19, 2025, the company has 74 employees. See our rating of the largest employees — is InflaRx N.V. on this list?
Like other stocks, IF0 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade InflaRx N.V. stock right from TradingView charts — choose your broker and connect to your account.